TrialContemporary clinical trials2021

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse.

Bhavna Oza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.